Literature DB >> 21177241

Elderly patients with schizophrenia and depression: diagnosis and treatment.

Kandi Felmet1, Sidney Zisook, John W Kasckow.   

Abstract

BACKGROUND: The treatment of older patients with schizophrenia and depressive symptoms poses many challenges for clinicians. Current classifications of depressive symptoms in patients with schizophrenia include: Major Depressive Episodes that occur in patients with schizophrenia and are not classified as schizoaffective disorder, Schizoaffective Disorder, and Schizophrenia with subsyndromal depression in which depressive symptoms do not meet criteria for Major Depression. Research indicates that the presence of any of these depressive symptoms negatively impacts the lives of patients suffering from schizophrenia-spectrum disorders.
PURPOSE: The purpose of this paper is to review the literature related to older patients with schizophrenia-spectrum disorders and co-occurring depressive symptoms, and to guide mental health professionals to better understand the diagnosis and treatment of depressive symptoms in patients with schizophrenia.
CONCLUSIONS: The treatment of elderly patients with schizophrenia and depressive symptoms includes first reassessing the diagnosis to make sure symptoms are not due to a comorbid condition, metabolic problems or medications. If these are ruled out, pharmacological agents in combination with psychosocial interventions are important treatments for older patients with schizophrenia and depressive symptoms. A careful assessment of each patient is needed in order to determine which antipsychotic would be optimal for their care; second-generation antipsychotics are the most commonly used antipsychotics. Augmentation with an antidepressant medication can be helpful for the elderly patient with schizophrenia and depressive symptoms. More research with pharmacologic and psychosocial interventions is needed, however, to better understand how to treat this population of elderly patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21177241      PMCID: PMC3062362          DOI: 10.3371/CSRP.4.4.4

Source DB:  PubMed          Journal:  Clin Schizophr Relat Psychoses        ISSN: 1935-1232


  157 in total

1.  A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months.

Authors:  A Bechdolf; D Köhn; B Knost; R Pukrop; J Klosterkötter
Journal:  Acta Psychiatr Scand       Date:  2005-09       Impact factor: 6.392

2.  Postpsychotic depression in schizophrenics.

Authors:  M J Stern; J A Pillsbury; S M Sonnenberg
Journal:  Compr Psychiatry       Date:  1972 Nov-Dec       Impact factor: 3.735

Review 3.  Drug-induced psychosis and depression in the elderly.

Authors:  K A Wood; M J Harris; A Morreale; A L Rizos
Journal:  Psychiatr Clin North Am       Date:  1988-03

Review 4.  Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death.

Authors:  A H Glassman; J T Bigger
Journal:  Am J Psychiatry       Date:  2001-11       Impact factor: 18.112

5.  "Postpsychotic depression" and residual schizophrenia in a mental health hospital.

Authors:  M C Mauri; V Laini; R Barone; A Clemente; L S Volonteri; G Cerveri; C Steinhilber; M Fornier
Journal:  Encephale       Date:  2000 Nov-Dec       Impact factor: 1.291

6.  Risperidone in the treatment of elderly patients with psychotic disorders.

Authors:  S Madhusoodanan; M Brecher; R Brenner; J Kasckow; M Kunik; A E Negrón; N Pomara
Journal:  Am J Geriatr Psychiatry       Date:  1999       Impact factor: 4.105

Review 7.  Posttraumatic stress disorder in older adults: a conceptual review.

Authors:  P M Averill; J G Beck
Journal:  J Anxiety Disord       Date:  2000 Mar-Apr

8.  Specificity of the Calgary Depression Scale for schizophrenics.

Authors:  D Addington; J Addington; E Maticka-Tyndale
Journal:  Schizophr Res       Date:  1994-02       Impact factor: 4.939

9.  Characterisation of depression in patients with schizophrenia.

Authors:  Adrian Heald; Julie Morris; Som D Soni
Journal:  Indian J Med Res       Date:  2008-06       Impact factor: 2.375

10.  Examining the validity of DSM-III-R schizoaffective disorder and its putative subtypes in the Roscommon Family Study.

Authors:  K S Kendler; M McGuire; A M Gruenberg; D Walsh
Journal:  Am J Psychiatry       Date:  1995-05       Impact factor: 18.112

View more
  8 in total

1.  Suicidal behavior in the older patient with schizophrenia.

Authors:  John Kasckow; Lori Montross; Laurie Prunty; Lauren Fox; Sidney Zisook
Journal:  Aging health       Date:  2011-06

Review 2.  Use of atypical antipsychotics in the elderly: a clinical review.

Authors:  Pietro Gareri; Cristina Segura-García; Valeria Graziella Laura Manfredi; Antonella Bruni; Paola Ciambrone; Gregorio Cerminara; Giovambattista De Sarro; Pasquale De Fazio
Journal:  Clin Interv Aging       Date:  2014-08-16       Impact factor: 4.458

3.  On the use of a Modified Kubler-Ross Model of Grief to Treat Bereavement in Schizophrenia.

Authors:  Bolaji Yoade; Nkolika Odenigbo; Jaquana Jones; Jisha Kallikkadan; Ayodeji Jolayemi
Journal:  Cureus       Date:  2020-12-12

4.  The association between ozone and fine particles and mental health-related emergency department visits in California, 2005-2013.

Authors:  Angela-Maithy Nguyen; Brian J Malig; Rupa Basu
Journal:  PLoS One       Date:  2021-04-02       Impact factor: 3.240

5.  Prevalence, Influencing Factors, and Cognitive Characteristics of Depressive Symptoms in Elderly Patients with Schizophrenia.

Authors:  Yaopian Chen; Wei Li
Journal:  Neuropsychiatr Dis Treat       Date:  2021-12-14       Impact factor: 2.570

6.  Forms of antipsychotic therapy: improved individual outcomes under personalised treatment of schizophrenia focused on depression.

Authors:  Zoja Babinkostova; Branislav Stefanovski
Journal:  EPMA J       Date:  2011-08-12       Impact factor: 6.543

7.  Paroxetine combined with olanzapine in the treatment of schizophrenia.

Authors:  Ning Wang; Na Zheng; Mei Dong; Jin He
Journal:  Pak J Med Sci       Date:  2020 Mar-Apr       Impact factor: 1.088

8.  Homozygosity in the APOE 3 Polymorphism Is Associated With Less Depression and Higher Serum Low-Density Lipoprotein in Chinese Elderly Schizophrenics.

Authors:  Wei Li; Chunxia Ban; Ling Yue; Lin Sun; Xia Li; Shifu Xiao
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-15       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.